By using Oracle Health Sciences Network, Joslin joins a growing list of healthcare provider participants which will expand clinical trial research for its patients through real-time collaboration with the industry.
By joining the network, the center will draw from a wide pool of clinical data to accelerate and expand its research initiatives and support industry collaboration.
In order to support its research initiatives, Joslin will upload authorized de-identified clinical data into its own, secure environment within the Oracle Health Sciences Network cloud.
According to the firms, pharmaceutical companies and clinical trial sponsors will also benefit from the de-identified data by streamlining the process to identify suitable patients for enrollment in clinical trials, advancing research and improving Joslin’s ability to collaborate with the health sciences community.
Joslin Diabetes Center president and CEO John Brooks said the company’s goal is to improve diabetes care; and research is an important component of that work.
"To optimize research productivity and insight today, no organization can go it alone — collaboration is essential to success," Brooks said.
"Oracle Health Sciences Network will provide a secure environment to extend access to critical data and foster collaboration across the health sciences industry."
Oracle Health Sciences global vice president Jonathan Sheldon said, "We welcome Joslin to our rapidly growing network and look forward to helping to support the center’s goal of advancing diabetes treatments and patient care."